Clinical trials: Palliative Cancer
Ovarian Cancer, Endometrial Cancer
Registry Platform Ovarian and Endometrial Cancer
The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of…
- Conditions
- Ovarian Cancer, Endometrial Cancer, Ovary Neoplasm, Endometrial Neoplasms
- Trial name
- SMARAGD (NCT05129969)
- Testing
- Physician's choice according to patient's needs.
- Where
- Germany
- Volunteers
- 1,975 people
- Sponsor
- iOMEDICO AG
Biliary Strictures Caused by Malignant Neoplasms
Study of the WallFlex™ Biliary Partially-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction
This is a a prospective study of the WallFlex™ Biliary Partially-covered Stent designed to collect data to support regulatory clearance by the FDA in the United States and to determine the functionality of the WallFlex™ Biliary…
- Trial name
- NCT00713427
- Testing
- WallFlex™ Biliary Partially-Covered Stent
- Where
- 6 sites in Belgium, France and 4 more
- Volunteers
- 70 people
- Sponsor
- Boston Scientific Corporation
GI Cancer
Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy
Gastric, biliary and pancreatic cancer are commonly malignancies from gastro- intestinal tract in Taiwan. Because lack of specific symptoms at presentation and effective screening methodology, majority of these patients are…
- Trial name
- NCT06040801
- Testing
- Frailty intervention measures
- Where
- Taiwan
- Volunteers
- 138 people
- Sponsor
- Chang Gung Memorial Hospital
Psychological Stress, Suffering
Art Therapy in Palliative Care: Study of Identification and Understanding of the Mechanisms of Change in the Patient
This study evaluates from the patient's perspective which elements of the own artistic creative process are the source of a beneficial change for him/her and how those elements influence in their end of life experience.
- Conditions
- Psychological Stress, Suffering, Advanced Cancers
- Trial name
- NCT02801045
- Testing
- art therapy
- Where
- Spain
- Volunteers
- 103 people
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
End Stage Cancer
Artificial Intelligence-based Mortality Prediction Among Cancer Patients in the Hospice Ward
The purpose of this study is to develop a novel deep-learning-based survival prediction model employing patient activity data recorded by a wearable device.
- Trial name
- NCT04883879
- Where
- Taiwan
- Volunteers
- 80 people
- Sponsor
- Taipei Medical University
Malignant Disease, Metastasis
Palliative Radiation Oncology Chief's Clinic
The proposed study represents a quality improvement study of a recently-developed dedicated radiation oncology subspecialty clinic with the goal of improving timeliness of palliative radiation therapy and improving resident…
- Trial name
- PROCC (NCT03995927)
- Testing
- Data collection and analysis, Quality of Life Questionnaire
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Wake Forest University Health Sciences
Cancer
Post-chemotherapy Symptom Management SMART
Survivors of solid tumors (N=451) who completed curative intent chemotherapy for a solid tumor within the past 2 years were interviewed at baseline and stratified as high or low need for symptom management based on comorbidity…
- Trial name
- NCT03494166
- Testing
- Start with SMSH+TIPC, Start with SMSH alone
- Where
- 2 sites in United States
- Volunteers
- 498 people
- Sponsor
- University of Arizona
Triple Negative Breast Cancer, Uterine Cervical Cancer
Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy
The aim of the study is to evaluate the response to four schemes of treatment with novel diagnostic tools - Immuno-PET and proteomics as well as standard imaging (magnetic resonsonce imaging and computed tomography).
- Conditions
- Triple Negative Breast Cancer, Uterine Cervical Cancer, Uterine Corpus Cancer, Malignant Melanoma
- Trial name
- INTROSPECTION (NCT06976021)
- Testing
- Baseline 89-Zr Pembrolizumab Immuno PET-CT, Proteomic assay, Follow-up 89-Zr Pembrolizumab Immuno PET-CT
- Volunteers
- 60 people
- Sponsor
- Maria Sklodowska-Curie National Research Institute of Oncology
Vitamin D Deficiency
'Palliative-D' Vitamin D to Palliative Cancer Patients
To test the hypothesis that vitamin D treatment during 12 weeks to palliative cancer patients can decrease opioid consumption, fatigue and infectious burden and increase quality of life.
- Trial name
- Palliative-D (NCT03038516)
- Testing
- Cholecalciferol
- Where
- 3 sites in Sweden
- Volunteers
- 244 people
- Sponsor
- Region Stockholm
Hepatocellular Carcinoma
Prevention of Hand-foot Skin Reaction
Sorafenib-induced hand-foot skin reaction (HFSR) is a dose-dependent side effect in patients with advance hepatocellular carcinoma (HCC).
- Trial name
- NCT04568330
- Testing
- best support care, moisture cream, 10% urea-based cream
- Volunteers
- 129 people
- Sponsor
- Taipei Veterans General Hospital, Taiwan
Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor
Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer
This randomized clinical trial studies palliative care in improving quality of life and symptoms in patients with stage III-IV pancreatic or ovarian cancer.
- Conditions
- Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer
- Trial name
- NCT01927393
- Testing
- palliative care, educational intervention, quality-of-life assessment
- Where
- United States
- Sponsor
- City of Hope Medical Center
Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment
Symptom Management in African-American Men With Localized Prostate Cancer
RATIONALE: Gathering information about symptom management from patients with localized prostate cancer may help doctors improve patients' quality of life.
- Trial name
- NCT00767845
- Testing
- questionnaire/survey administration
- Where
- United States
- Sponsor
- Baylor College of Medicine
Chronic Lymphocytic Leukemia, Myelodysplastic Syndromes
MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies
Randomized unblinded interventional clinical trial: Arm Intervention Experimental arm (n=150): Intervention group Administration of the MyPal ePRO system the intervention group will use the ePRO tools provided in the project.
- Trial name
- NCT04370457
- Testing
- Administration of the MyPal ePRO system
- Where
- Italy
- Volunteers
- 300 people
- Sponsor
- Centre for Research and Technology Hellas
Cancer
Diamorphine or Alfentanil for Subcutaneous Use in Hospice In-patients?
OBJECTIVES: How does Alfentanil compare with the standard drug Diamorphine for subcutaneous analgesia in the palliative care setting? STUDY DESIGN: An open-label pilot comparison between alfentanil and diamorphine for palliative…
- Trial name
- DASH (NCT01049672)
- Testing
- Alfentanil, Diamorphine
- Where
- United Kingdom
- Volunteers
- 18 people
- Sponsor
- Gloucestershire Hospitals NHS Foundation Trust
Symptom Managemen, Late Stage Lung Cancer
The Impact of Symptom Management Nursing Intervention on the QoL of Patients With Advanced Lung Cancer: Mediation of Self-management Efficacy and Regulation of Psychological Resilience
Symptom management nursing intervention can improve the self-management efficacy, psychological resilience, and QoL of patients with advanced lung cancer.
- Conditions
- Symptom Managemen, Late Stage Lung Cancer, QoL, Self Management Efficacy
- Trial name
- NCT07679165
- Testing
- routine nursing group, standardized systematic SM nursing group
- Where
- China
- Volunteers
- 176 people
- Sponsor
- Jie Zeng
Other Cancer, Gastrointestinal Cancer
Symptom Management Implementation of Patient Reported Outcomes in Oncology
Deficits in the management of common symptoms cause substantial morbidity for cancer patients.Because the health care delivery system is structured to be reactive and not proactive, there are missed opportunities to optimize…
- Conditions
- Other Cancer, Gastrointestinal Cancer, Thoracic Cancer, Gynecologic Cancer
- Trial name
- SIMPRO (NCT03850912)
- Testing
- Stakeholder Survey (Control Period), Stakeholder Survey (Intervention Period), Qualitative Interview
- Where
- 6 sites in United States
- Volunteers
- 42,808 people
- Sponsor
- Dana-Farber Cancer Institute
Cancer, Adherence to Medication Regime
Mobile Application to Assist Adherence to Oral Anticancer Agents and Symptom Management
The use of oral anticancer agents (OAAs) in cancer treatment has increased especially in the last two decades. The use of mobile health technologies in the management of OAA can be beneficial in terms of treatment adherence and…
- Conditions
- Cancer, Adherence to Medication Regime, Symptom Management
- Trial name
- NCT04626830
- Testing
- Mobile Application Intervention
- Where
- Turkey (Türkiye)
- Volunteers
- 77 people, healthy volunteers welcome
- Sponsor
- Baskent University
Cancer, Cachexia
Resting Energy Expenditure in Palliative Cancer Patients
The study purpose is to measure REE by indirect calorimetry and to determine limits of agreement with confidence intervals between measured REE and predictive equations for determination of energy requirements in patients with…
- Trial name
- REPAT (NCT06206785)
- Where
- Norway
- Volunteers
- 160 people
- Sponsor
- Norwegian University of Science and Technology
Palliative Radiotherapy, Metastatic Cancer (Different Solid Tumour Types)
Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial
This is a prospective single-center single-arm Phase II trial of HART for patients with metastatic cancer. The primary objective is to assess the incidence of acute GI toxicity following HART.
- Trial name
- HART (NCT06778408)
- Testing
- Hybrid Palliative Radiation Therapy
- Where
- United States
- Volunteers
- 103 people
- Sponsor
- University of Vermont Medical Center
Neoplasms Pancreatic, Cachexia; Cancer
The Effect of Cannabis in Pancreatic Cancer
Cannabinoids are known to increase appetite, but THC components have psychogenic properties too. CBD is the main component in the plant, and have only minimal psychogenic effects.
- Conditions
- Neoplasms Pancreatic, Cachexia; Cancer, Cannabis, Appetite Loss
- Trial name
- NCT03245658
- Testing
- THC and CBD Mixture
- Where
- Denmark
- Sponsor
- Jens Rikardt Andersen
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.